Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = thromboemolism

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
5 pages, 2460 KB  
Case Report
A Patient with Sickle Cell Disease and Recurrent Venous Thromboembolism after Renal Transplantation
by Rosario Di Maggio, Alessandra Giuliano, Disma Renda, Giuseppina Calvaruso, Simona Raso, Lorella Pitrolo, Antonio Carroccio and Aurelio Maggio
Thalass. Rep. 2022, 12(3), 85-89; https://doi.org/10.3390/thalassrep12030013 - 20 Jul 2022
Cited by 1 | Viewed by 2527
Abstract
Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidney disease, renal transplantation [...] Read more.
Venous thromboembolism (VTE) is a life-threatening complication, especially in case of recurrence. The appropriate duration of anticoagulant treatment following the first event is crucial. Risk factors that increase the risk of recurrence of VTE are many, and include medications, kidney disease, renal transplantation (RT), and a diagnosis of sickle cell disease (SCD). There are currently no guidelines that define the duration of anticoagulant therapy after the first event in a patient with RT. We report a case of recurring episodes of VTE after RT in a SCD patient. Our case suggests that the use of a long-term anticoagulant treatment may be recommended in patients with SCD and RT after the first event of VTE. Full article
Show Figures

Figure 1

Back to TopTop